Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDRY.L Regulatory News (SDRY)

  • There is currently no data for SDRY

Form 8.5 (EPT/RI)

21 Feb 2024 09:09

RNS Number : 9220D
Liberum Capital Limited
21 February 2024

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Superdry Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Superdry Plc

(d) Date dealing undertaken:

20th February 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD 5p

Purchase

395,889

0.42

0.375

ORD 5p

Sale

279,713

0.422

0.345

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Date of disclosure:

21st February 2024

Contact name:

Shivani Ghiraiya

Telephone number:

020 3100 2213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FERGCGDDLGDDGSB
Date   Source Headline
15th Sep 20174:54 pmRNSDirector/PDMR Shareholding
12th Sep 20171:16 pmRNSResult of AGM
12th Sep 201712:00 pmRNSFounder Share Plan
8th Sep 20175:36 pmRNSHolding(s) in Company
1st Sep 20174:47 pmRNSHolding(s) in Company
31st Aug 20172:50 pmRNSTotal Voting Rights
21st Aug 20171:41 pmRNSDirector/PDMR Shareholding
17th Aug 20179:43 amRNSHolding(s) in Company
16th Aug 20171:33 pmRNSDirector/PDMR Shareholding
15th Aug 20172:32 pmRNSDirector/PDMR Shareholding
15th Aug 20171:03 pmRNSHolding(s) in Company
10th Aug 201710:44 amRNSAnnual Report and Notice of AGM
31st Jul 201712:40 pmRNSTotal Voting Rights
25th Jul 20175:11 pmRNSDirector/PDMR Shareholding
25th Jul 20174:25 pmRNSDirector/PDMR Shareholding
14th Jul 20171:58 pmRNSDirector/PDMR Shareholding
10th Jul 20174:06 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSDirectorate Change
3rd Jul 20177:00 amRNSFinal Results
30th Jun 20172:13 pmRNSTotal Voting Rights
29th Jun 20173:15 pmRNSConfirmation of full year results
15th Jun 20173:53 pmRNSDirector/PDMR Shareholding
6th Jun 20174:55 pmRNSHolding(s) in Company
31st May 20178:54 amRNSTotal Voting Rights
26th May 201710:03 amRNSDirector Declaration
17th May 20173:32 pmRNSDirector/PDMR Shareholding
11th May 20177:00 amRNSFull Year Pre-Close Trading Statement
28th Apr 20173:12 pmRNSTotal Voting Rights
26th Apr 20172:18 pmRNSDirector/PDMR Shareholding
20th Apr 20172:13 pmRNSDirector/PDMR Shareholding
19th Apr 20174:49 pmRNSDirector/PDMR Shareholding
12th Apr 20173:19 pmRNSDirector/PDMR Shareholding
31st Mar 20173:47 pmRNSTotal Voting Rights
24th Mar 20179:58 amRNSAudit Tender Process
23rd Mar 201710:00 amRNSBlock listing Interim Review
15th Mar 201712:47 pmRNSDirector/PDMR Shareholding
28th Feb 20171:50 pmRNSDirector/PDMR Shareholding
28th Feb 20179:27 amRNSTotal Voting Rights
22nd Feb 20174:37 pmRNSDirector/PDMR Shareholding
14th Feb 201712:50 pmRNSDirector/PDMR Shareholding
6th Feb 201712:10 pmRNSDirector/PDMR Shareholding
31st Jan 201710:54 amRNSTotal Voting Rights
20th Jan 20173:25 pmRNSHolding(s) in Company
20th Jan 20173:21 pmRNSDirector/PDMR Shareholding
16th Jan 20172:26 pmRNSDirector/PDMR Shareholding
12th Jan 20177:00 amRNSHalf-year Report
30th Dec 201610:20 amRNSTotal Voting Rights
19th Dec 201610:40 amRNSHolding(s) in Company
16th Dec 201611:12 amRNSHolding(s) in Company
14th Dec 20164:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.